Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?

Area of Science:

• Biomaterials Science
• Regulatory Affairs
• Pharmaceutics

Background:

• Substance-based medical devices (SB-MD) often utilize mucoadhesive polymers for targeted drug delivery.
• Mucoadhesive formulations are designed for various administration routes, including oral, buccal, nasal, and vaginal.
• While the functional properties of these polymers are known, their precise mechanisms of action remain unclear.

Purpose of the Study:

• To elucidate the regulatory landscape for mucoadhesive SB-MD.
• To clarify the underlying mechanisms of mucoadhesion in SB-MD.
• To provide guidance for successful regulatory submissions and approvals.

Main Methods:

• Review of regulatory guidelines pertaining to SB-MD.
• Analysis of the physicochemical and functional properties of mucoadhesive polymers.
• Case study focusing on Hyaluronic acid as a representative mucoadhesive polymer.

Main Results:

• Identified regulatory uncertainties surrounding mucoadhesive SB-MD.
• Highlighted the importance of well-characterized mucoadhesive polymers and their mechanisms.
• Presented Hyaluronic acid as a model for understanding mucoadhesion in SB-MD.

Conclusions:

• A clear understanding of mucoadhesive mechanisms is crucial for regulatory compliance.
• Effective characterization of SB-MD components supports regulatory assessment.
• This work aids in navigating the approval process for mucoadhesive medical devices.